Abstract | BACKGROUND: METHODS: RESULTS: 95 patients were enrolled into this study. In the neoadjuvant radiotherapy group (n = 45), 12 patients showed gross radiological reduction in extent of PVTT. In 6 patients, the extent of PVTT was reduced to be within the ipsilateral side of the portal vein. When compared with patients who underwent surgery alone (n = 50), neoadjuvant radiotherapy significantly decreased the rates of HCC recurrence and HCC-related death, with hazard ratios of 0.36 (95% CI, 0.19-0.70) and 0.32 (95% CI, 0.18-0.57), respectively. CONCLUSION:
|
Authors | Nan Li, Shuang Feng, Jie Xue, Xu-Biao Wei, Jie Shi, Wei-Xing Guo, Wan-Yee Lau, Meng-Chao Wu, Shu-Qun Cheng, Yan Meng |
Journal | HPB : the official journal of the International Hepato Pancreato Biliary Association
(HPB (Oxford))
Vol. 18
Issue 6
Pg. 549-56
(06 2016)
ISSN: 1477-2574 [Electronic] England |
PMID | 27317960
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Copyright © 2016 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved. |
Topics |
- Adult
- Aged
- Carcinoma, Hepatocellular
(diagnostic imaging, pathology, therapy)
- Dose Fractionation, Radiation
- Hepatectomy
(adverse effects, mortality)
- Humans
- Kaplan-Meier Estimate
- Liver Neoplasms
(diagnostic imaging, pathology, therapy)
- Male
- Middle Aged
- Neoadjuvant Therapy
(adverse effects, mortality)
- Neoplasm Recurrence, Local
- Neoplastic Cells, Circulating
(pathology, radiation effects)
- Portal Vein
(diagnostic imaging, pathology)
- Radiotherapy, Adjuvant
- Radiotherapy, Conformal
(adverse effects, mortality)
- Risk Factors
- Time Factors
- Tomography, X-Ray Computed
- Treatment Outcome
- Venous Thrombosis
(diagnostic imaging, pathology, therapy)
|